ArticleFrontiers in cell and developmental biology2021

Oncogenic Chromatin Modifier KAT2A Activates MCT1 to Drive the Glycolytic Process and Tumor Progression in Renal Cell Carcinoma.

Yuanyuan Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.